{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T15:13:51Z","timestamp":1788880431354,"version":"build-2803163510"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:00:00Z","timestamp":1788825600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:00:00Z","timestamp":1788825600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"DOI":"10.1007\/s00428-026-04697-7","type":"journal-article","created":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T03:11:41Z","timestamp":1788837101000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Gastric carcinoma classification in the WHO 6th edition (2026): Updated framework and emerging entities"],"prefix":"10.1007","author":[{"given":"Ryoji","family":"Kushima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,8]]},"reference":[{"key":"4697_CR1","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/apm.1965.64.1.31","volume":"64","author":"P Lauren","year":"1965","unstructured":"Lauren P (1965) The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type. Acta Pathol Microbiol Scand 64:31\u201349. https:\/\/doi.org\/10.1111\/apm.1965.64.1.31","journal-title":"Acta Pathol Microbiol Scand"},{"key":"4697_CR2","first-page":"251","volume":"59","author":"K Nakamura","year":"1968","unstructured":"Nakamura K, Sugano H, Takagi K (1968) Carcinoma of the stomach in incipient phase: its histogenesis and histological appearances. Gan 59:251\u2013258","journal-title":"Gan"},{"key":"4697_CR3","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.1002\/1097-0142(197706)39:6","volume":"39","author":"SC Ming","year":"1977","unstructured":"Ming SC (1977) Gastric carcinoma. A pathobiological classification. Cancer 39:2475\u20132485. https:\/\/doi.org\/10.1002\/1097-0142(197706)39:6","journal-title":"Cancer"},{"key":"4697_CR4","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1136\/gut.33.5.606","volume":"33","author":"N Goseki","year":"1992","unstructured":"Goseki N, Takizawa T, Koike M (1992) Differences in the mode of the extension of gastric cancer classified by histological type: new histological classification of gastric carcinoma. Gut 33:606\u2013612. https:\/\/doi.org\/10.1136\/gut.33.5.606","journal-title":"Gut"},{"key":"4697_CR5","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S0968-6053(97)80008-7","volume":"4","author":"F Carneiro","year":"1997","unstructured":"Carneiro F (1997) Classification of gastric carcinoma. Curr Diagn Pathol 4:51\u201359","journal-title":"Curr Diagn Pathol"},{"key":"4697_CR6","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s10120-011-0041-5","volume":"14","author":"Japanese Gastric Cancer Association","year":"2011","unstructured":"Japanese Gastric Cancer Association (2011) Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer 14:101\u2013112. https:\/\/doi.org\/10.1007\/s10120-011-0041-5","journal-title":"Gastric Cancer"},{"key":"4697_CR7","volume-title":"Japanese Classification of Gastric Carcinoma","author":"Japanese Gastric Cancer Association","year":"2026","unstructured":"Japanese Gastric Cancer Association (2026) Japanese Classification of Gastric Carcinoma, 16th edn. Kanehara Shuppan, Tokyo. (in Japanese)","edition":"16"},{"key":"4697_CR8","first-page":"39","volume-title":"World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Digestive System","author":"C Fenoglio-Preiser","year":"2000","unstructured":"Fenoglio-Preiser C, Carneiro F, Correa P et al (2000) Gastric carcinoma. In: Hamilton SR, Aaltonen LA (eds) World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Digestive System. IARC, Lyon, pp 39\u201352"},{"key":"4697_CR9","first-page":"48","volume-title":"WHO Classification of Tumours of the Digestive System","author":"GY Lauwers","year":"2010","unstructured":"Lauwers GY, Carneiro F, Graham DY et al (2010) Gastric carcinoma. In: Bosman FT, Carneiro F, Hruban RH, Theise ND (eds) WHO Classification of Tumours of the Digestive System, 4th edn. IARC, Lyon, pp 48\u201358","edition":"4"},{"key":"4697_CR10","first-page":"85","volume-title":"WHO Classification of Tumours: Digestive System Tumours","author":"F Carneiro","year":"2019","unstructured":"Carneiro F, Fukayama M, Grabsch HI (2019) Gastric adenocarcinoma. (eds) WHO Classification of Tumours: Digestive System Tumours, 5th edn. IARC, Lyon, pp 85\u201395. WHO Classification of Tumours Editorial Board","edition":"5"},{"key":"4697_CR11","volume-title":"WHO Classification of Tumours online: Digestive System Tumours","author":"R Kushima","year":"2026","unstructured":"Kushima R, Carneiro F, Grabsch H et al (2026) Gastric adenocarcinoma. (eds) WHO Classification of Tumours: Digestive System Tumours, 6th edn. IARC, Lyon. (in press). WHO Classification of Tumours Editorial Board. https:\/\/tumourclassification.iarc.who.int\/chaptercontent\/72\/27","edition":"6"},{"key":"4697_CR12","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s10120-006-0381-8","volume":"9","author":"R Kushima","year":"2006","unstructured":"Kushima R, Vieth M, Borchard F et al (2006) Gastric-type well-differentiated adenocarcinoma and pyloric gland adenoma of the stomach. Gastric Cancer 9:177\u2013184. https:\/\/doi.org\/10.1007\/s10120-006-0381-8","journal-title":"Gastric Cancer"},{"key":"4697_CR13","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1007\/s10120-012-0173-2","volume":"16","author":"N Okamoto","year":"2013","unstructured":"Okamoto N, Kawachi H, Yoshida T (2013) Crawling-type adenocarcinoma of the stomach: a distinct entity preceding poorly differentiated adenocarcinoma. Gastric Cancer 16:220\u2013232. https:\/\/doi.org\/10.1007\/s10120-012-0173-2","journal-title":"Gastric Cancer"},{"key":"4697_CR14","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1038\/modpathol.2013.98","volume":"26","author":"T Ushiku","year":"2013","unstructured":"Ushiku T, Arnason T, Ban S et al (2013) Very well-differentiated gastric carcinoma of intestinal type: analysis of diagnostic criteria. Mod Pathol 26:1620\u20131631. https:\/\/doi.org\/10.1038\/modpathol.2013.98","journal-title":"Mod Pathol"},{"key":"4697_CR15","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1055\/s-0032-131016","volume":"44","author":"KJ Kang","year":"2012","unstructured":"Kang KJ, Kim KM, Kim JJ (2012) Gastric extremely well-differentiated intestinal-type adenocarcinoma: a challenging lesion to achieve complete endoscopic resection. Endoscopy 44:949\u2013952. https:\/\/doi.org\/10.1055\/s-0032-131016","journal-title":"Endoscopy"},{"key":"4697_CR16","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1007\/s10120-024-01507-4","volume":"27","author":"H Noda","year":"2024","unstructured":"Noda H, Sakata S, Baba S et al (2024) Early gastric cancer with RhoGAP fusion is linked to frequent nodal metastasis and a part of microtubular-mucocellular histology. Gastric Cancer 27:772\u2013784. https:\/\/doi.org\/10.1007\/s10120-024-01507-4","journal-title":"Gastric Cancer"},{"key":"4697_CR17","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1038\/s41379-018-0181-x","volume":"32","author":"T Hashimoto","year":"2019","unstructured":"Hashimoto T, Ogawa R, Tang TY et al (2019) RHOA mutations and CLDN18-ARHGAP fusions in intestinal-type adenocarcinoma with anastomosing glands of the stomach. Mod Pathol 32:568\u2013575. https:\/\/doi.org\/10.1038\/s41379-018-0181-x","journal-title":"Mod Pathol"},{"key":"4697_CR18","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1007\/s00535-012-0696-7","volume":"48","author":"M Sekiguchi","year":"2013","unstructured":"Sekiguchi M, Sekine S, Oda I et al (2013) Risk factors for lymphatic and venous involvement in endoscopically resected gastric cancer. J Gastroenterol 48:706\u2013712. https:\/\/doi.org\/10.1007\/s00535-012-0696-7","journal-title":"J Gastroenterol"},{"key":"4697_CR19","doi-asserted-by":"publisher","first-page":"117","DOI":"10.7150\/jca.17326","volume":"8","author":"H Yu","year":"2017","unstructured":"Yu H, Fang C, Chen L et al (2017) Worse prognosis in papillary, compared to tubular, early gastric carcinoma. J Cancer 8:117\u2013123. https:\/\/doi.org\/10.7150\/jca.17326","journal-title":"J Cancer"},{"key":"4697_CR20","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1097\/PAS.0000000000001759","volume":"45","author":"Y Cheng","year":"2021","unstructured":"Cheng Y, Du M, Zhou X et al (2021) High-grade papillary early gastric carcinoma with high risk for lymph node metastasis and poor prognosis: a clinicopathologic study of 96 cases among 1136 consecutive radical gastrectomies. Am J Surg Pathol 45:1661\u20131668. https:\/\/doi.org\/10.1097\/PAS.0000000000001759","journal-title":"Am J Surg Pathol"},{"key":"4697_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10120-018-0868-0","volume":"22","author":"C Mariette","year":"2019","unstructured":"Mariette C, Carneiro F, Grabsch HI et al (2019) Consensus on the pathological definition and classification of poorly cohesive gastric carcinoma. Gastric Cancer 22:1\u20139. https:\/\/doi.org\/10.1007\/s10120-018-0868-0","journal-title":"Gastric Cancer"},{"key":"4697_CR22","volume-title":"Histological Typing of Gastric and Oesophageal Tumours","author":"K Oota","year":"1977","unstructured":"Oota K, Sobin LH (1977) Histological Typing of Gastric and Oesophageal Tumours. World Health Organization, Geneva"},{"key":"4697_CR23","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/BF00712735","volume":"411","author":"H Sugihara","year":"1987","unstructured":"Sugihara H, Hattori T, Fukuda M et al (1987) Cell proliferation and differentiation in intramucosal and advanced signet ring cell carcinomas of the human stomach. Virchows Arch Pathol Anat Histopathol 411:117\u2013127. https:\/\/doi.org\/10.1007\/BF00712735","journal-title":"Virchows Arch Pathol Anat Histopathol"},{"key":"4697_CR24","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1007\/s10120-019-00960-w","volume":"22","author":"T Arai","year":"2019","unstructured":"Arai T (2019) Where does signet-ring cell carcinoma come from and where does it go? Gastric Cancer 22:651\u2013652. https:\/\/doi.org\/10.1007\/s10120-019-00960-w","journal-title":"Gastric Cancer"},{"key":"4697_CR25","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1002\/path.4761","volume":"240","author":"H Rokutan","year":"2016","unstructured":"Rokutan H, Hosoda F, Hama N et al (2016) Comprehensive mutation profiling of mucinous gastric carcinoma. J Pathol 240:137\u2013148. https:\/\/doi.org\/10.1002\/path.4761","journal-title":"J Pathol"},{"key":"4697_CR26","first-page":"459","volume":"79","author":"JC Machado","year":"1999","unstructured":"Machado JC, Soares P, Carneiro F et al (1999) E-cadherin gene mutations provide a genetic basis for the phenotypic divergence of mixed gastric carcinomas. Lab Invest 79:459\u2013465","journal-title":"Lab Invest"},{"key":"4697_CR27","first-page":"39","volume":"143","author":"S Stelzner","year":"1997","unstructured":"Stelzner S, Emmrich P (1997) The mixed type in Laur\u00e9n\u2019s classification of gastric carcinoma. Histologic description and biologic behavior. Gen Diagn Pathol 143:39\u201348","journal-title":"Gen Diagn Pathol"},{"key":"4697_CR28","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/s00428-007-0572-7","volume":"452","author":"HC Zheng","year":"2008","unstructured":"Zheng HC, Li XH, Hara T et al (2008) Mixed-type gastric carcinomas exhibit more aggressive features and indicate the histogenesis of carcinomas. Virchows Arch 452:525\u2013534. https:\/\/doi.org\/10.1007\/s00428-007-0572-7","journal-title":"Virchows Arch"},{"key":"4697_CR29","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1002\/1097-0142(197607)38:1<232::aid-cncr2820380135>3.0.co;2-4","volume":"38","author":"H Watanabe","year":"1976","unstructured":"Watanabe H, Enjoji M, Imai T (1976) Gastric carcinoma with lymphoid stroma. Its morphologic characteristics and prognostic correlations. Cancer 38:232\u2013243. https:\/\/doi.org\/10.1002\/1097-0142(197607)38:1%3C232::aid-cncr2820380135%3E3.0.co;2-4","journal-title":"Cancer"},{"key":"4697_CR30","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1097\/PAS.0000000000001018","volume":"42","author":"E Hissong","year":"2018","unstructured":"Hissong E, Ramrattan G, Zhang P et al (2018) Gastric carcinomas with lymphoid stroma: an evaluation of the histopathologic and molecular features. Am J Surg Pathol 42:453\u2013462. https:\/\/doi.org\/10.1097\/PAS.0000000000001018","journal-title":"Am J Surg Pathol"},{"key":"4697_CR31","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.3390\/ijms19072079","volume":"19","author":"I Gullo","year":"2018","unstructured":"Gullo I, Carvalho J, Martins D et al (2018) The transcriptomic landscape of gastric cancer: insights into Epstein-Barr virus infected and microsatellite unstable tumors. Int J Mol Sci 19:2079. https:\/\/doi.org\/10.3390\/ijms19072079","journal-title":"Int J Mol Sci"},{"key":"4697_CR32","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1111\/den.13823","volume":"33","author":"Y Tsuji","year":"2021","unstructured":"Tsuji Y, Ushiku T, Shinozaki T et al (2021) Risk for lymph node metastasis in Epstein-Barr virus-associated gastric carcinoma with submucosal invasion. Dig Endosc 33:592\u2013597. https:\/\/doi.org\/10.1111\/den.13823","journal-title":"Dig Endosc"},{"key":"4697_CR33","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1007\/s10120-019-00963-7","volume":"22","author":"H Osumi","year":"2019","unstructured":"Osumi H, Kawachi H, Murai K et al (2019) Risk stratification for lymph node metastasis using Epstein-Barr virus status in submucosal invasive (pT1) gastric cancer without lymphovascular invasion: a multicenter observational study. Gastric Cancer 22:1176\u20131182. https:\/\/doi.org\/10.1007\/s10120-019-00963-7","journal-title":"Gastric Cancer"},{"key":"4697_CR34","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1097\/PAS.0b013e3181d1dcdd","volume":"34","author":"T Ushiku","year":"2010","unstructured":"Ushiku T, Shinozaki A, Shibahara J (2010) SALL4 represents fetal gut differentiation of gastric cancer, and is diagnostically useful in distinguishing hepatoid gastric carcinoma from hepatocellular carcinoma. Am J Surg Pathol 34:533\u2013540. https:\/\/doi.org\/10.1097\/PAS.0b013e3181d1dcdd","journal-title":"Am J Surg Pathol"},{"key":"4697_CR35","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s00428-023-03623-5","volume":"483","author":"A Abe","year":"2023","unstructured":"Abe A, Akazawa Y, Yatagai N (2023) Clinicopathological characteristics of gastric adenocarcinoma with enteroblastic differentiation and gastric adenocarcinoma with enteroblastic marker expression. Virchows Arch 483:405\u2013414. https:\/\/doi.org\/10.1007\/s00428-023-03623-5","journal-title":"Virchows Arch"},{"key":"4697_CR36","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1097\/PAS.0b013e3181e7043b","volume":"34","author":"JH Roh","year":"2010","unstructured":"Roh JH, Srivastava A, Lauwers GY et al (2010) Micropapillary carcinoma of stomach: a clinicopathologic and immunohistochemical study of 11 cases. Am J Surg Pathol 34:1139\u20131146. https:\/\/doi.org\/10.1097\/PAS.0b013e3181e7043b","journal-title":"Am J Surg Pathol"},{"key":"4697_CR37","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1111\/j.1365-2559.2011.04055.x","volume":"59","author":"T Ushiku","year":"2011","unstructured":"Ushiku T, Matsusaka K, Iwasaki Y et al (2011) Gastric carcinoma with invasive micropapillary pattern and its association with lymph node metastasis. Histopathology 59:1081\u20131089. https:\/\/doi.org\/10.1111\/j.1365-2559.2011.04055.x","journal-title":"Histopathology"},{"key":"4697_CR38","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s10120-014-0350-6","volume":"18","author":"Q Zhang","year":"2015","unstructured":"Zhang Q, Ming J, Zhang S et al (2015) Micropapillary component in gastric adenocarcinoma: an aggressive variant associated with poor prognosis. Gastric Cancer 18:93\u201399. https:\/\/doi.org\/10.1007\/s10120-014-0350-6","journal-title":"Gastric Cancer"},{"key":"4697_CR39","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1097\/PAS.0b013e3181d94d53","volume":"34","author":"H Ueyama","year":"2010","unstructured":"Ueyama H, Yao T, Nakashima Y et al (2010) Gastric adenocarcinoma of fundic gland type (chief cell predominant type): proposal for a new entity of gastric adenocarcinoma. Am J Surg Pathol 34:609\u2013619. https:\/\/doi.org\/10.1097\/PAS.0b013e3181d94d53","journal-title":"Am J Surg Pathol"},{"key":"4697_CR40","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1097\/PAS.0b013e31825033e7","volume":"36","author":"AD Singhi","year":"2012","unstructured":"Singhi AD, Lazenby AJ, Montgomery EA et al (2012) Gastric adenocarcinoma with chief cell differentiation: a proposal for reclassification as oxyntic gland polyp\/adenoma. Am J Surg Pathol 36:1030\u20131035. https:\/\/doi.org\/10.1097\/PAS.0b013e31825033e7","journal-title":"Am J Surg Pathol"},{"key":"4697_CR41","doi-asserted-by":"publisher","first-page":"2763","DOI":"10.2169\/internalmedicine.0552-22","volume":"62","author":"H Asahara","year":"2023","unstructured":"Asahara H, Takao T, Asahara Y et al (2023) Clinicopathological features and the prevalence of oxyntic gland neoplasm: a single-center retrospective study. Intern Med 62:2763\u20132774. https:\/\/doi.org\/10.2169\/internalmedicine.0552-22","journal-title":"Intern Med"},{"issue":"12","key":"4697_CR42","doi-asserted-by":"publisher","first-page":"e24697","DOI":"10.1097\/MD.0000000000024697","volume":"100","author":"Y Li","year":"2021","unstructured":"Li Y, Cui L, Chen Y et al (2021) Carcinosarcoma and sarcomatoid carcinoma of the stomach: Two case reports. Med (Baltim) 100(12):e24697. https:\/\/doi.org\/10.1097\/MD.0000000000024697","journal-title":"Med (Baltim)"},{"key":"4697_CR43","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/nature13480","volume":"513","author":"Cancer Genome Atlas Research Network","year":"2014","unstructured":"Cancer Genome Atlas Research Network (2014) Comprehensive molecular characterization of gastric adenocarcinoma. Nature 513:202\u2013209. https:\/\/doi.org\/10.1038\/nature13480","journal-title":"Nature"},{"key":"4697_CR44","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1007\/s10120-014-0402-y","volume":"18","author":"E Van Cutsem","year":"2015","unstructured":"Van Cutsem E, Bang YJ, Feng-Yi F et al (2015) HER2 screening data from ToGA: targeting HER2 in gastric and gastroesophageal junction cancer. Gastric Cancer 18:476\u2013484. https:\/\/doi.org\/10.1007\/s10120-014-0402-y","journal-title":"Gastric Cancer"},{"key":"4697_CR45","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1200\/JCO.2016.69.4836","volume":"35","author":"AN Bartley","year":"2017","unstructured":"Bartley AN, Washington MK, Colasacco C et al (2017) HER2 testing and clinical decision making in gastroesophageal adenocarcinoma: Guideline from the College of American Pathologists, American Society for Clinical Pathology, and the American Society of Clinical Oncology. J Clin Oncol 35:446\u2013464. https:\/\/doi.org\/10.1200\/JCO.2016.69.4836","journal-title":"J Clin Oncol"},{"key":"4697_CR46","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1016\/S0140-6736(23)00620-7","volume":"401","author":"K Shitara","year":"2023","unstructured":"Shitara K, Lordick F, Bang YJ et al (2023) Zolbetuximab plus mFOLFOX6 in patients with CLDN18.2-positive, HER2-negative, untreated, locally advanced unresectable or metastatic gastric or gastro-oesophageal junction adenocarcinoma (SPOTLIGHT): a multicentre, randomised, double-blind, phase 3 trial. Lancet 401:1655\u20131668. https:\/\/doi.org\/10.1016\/S0140-6736(23)00620-7","journal-title":"Lancet"},{"key":"4697_CR47","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1001\/jamaoncol.2016.6762","volume":"3","author":"EC Smyth","year":"2017","unstructured":"Smyth EC, Wotherspoon A, Peckitt C et al (2017) Mismatch Repair Deficiency, Microsatellite Instability, and Survival: An Exploratory Analysis of the Medical Research Council Adjuvant Gastric Infusional Chemotherapy (MAGIC) Trial. JAMA Oncol 3:1197\u20131203. https:\/\/doi.org\/10.1001\/jamaoncol.2016.6762","journal-title":"JAMA Oncol"},{"key":"4697_CR48","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S0140-6736(21)00797-2","volume":"398","author":"YY Janjigian","year":"2021","unstructured":"Janjigian YY, Shitara K, Moehler M et al (2021) First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial. Lancet 398:27\u201340. https:\/\/doi.org\/10.1016\/S0140-6736(21)00797-2","journal-title":"Lancet"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-026-04697-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00428-026-04697-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-026-04697-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T15:03:24Z","timestamp":1788879804000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00428-026-04697-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,8]]},"references-count":48,"alternative-id":["4697"],"URL":"https:\/\/doi.org\/10.1007\/s00428-026-04697-7","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,8]]},"assertion":[{"value":"5 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This manuscript is a review article based entirely on previously published literature (primarily the WHO classification) and does not involve any new human participants or animal subjects. Therefore, ethical approval was not required for this study.","order":1,"name":"Ethics","label":"Compliance with ethical standards","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The author declares that they have no conflict of interest.","order":2,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}